Overexpression of human epidermal growth factor receptor 2 in canine primary lung cancer
Open Access
- 1 January 2020
- journal article
- research article
- Published by Japanese Society of Veterinary Science in The Journal of Veterinary Medical Science
- Vol. 82 (6), 804-808
- https://doi.org/10.1292/jvms.20-0026
Abstract
Human epidermal growth factor receptor 2 (HER2) overexpression has been reported in various human cancers. HER2-targeted therapies showed clinical responses in humans with HER2-positive tumors. The incidence of canine primary lung cancer (cPLC) is increasing, but there are no effective systemic therapies for dogs with late-stage cPLC. HER2-targeted therapy could be an option for cPLC, but HER2 expression in cPLC remains unknown. We evaluated HER2 expression in cPLC. Immunohistochemical analysis revealed that 3 samples (19%) scored 3+; 8 (50%), 2+; 5 (31%); and 1+ and 0 (0%), 0. Of the cPLC tissues, 69% were HER2 positive (scored ≥2+). These data would lead to further evaluation of the role of HER2 in cPLC as a mechanism of malignancy and therapeutic target.Keywords
This publication has 23 references indexed in Scilit:
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline UpdateJournal of Clinical Oncology, 2013
- Lung Cancer That Harbors an HER2 Mutation: Epidemiologic Characteristics and Therapeutic PerspectivesJournal of Clinical Oncology, 2013
- HER2 Expression Beyond Breast Cancer: Therapeutic Implications for Gynecologic MalignanciesMolecular Diagnosis & Therapy, 2013
- EGFRoverexpression in canine primary lung cancer: pathogenetic implications and impact on survivalVeterinary and Comparative Oncology, 2012
- Comparative oncology: ErbB-1 and ErbB-2 homologues in canine cancer are susceptible to cetuximab and trastuzumab targetingMolecular Immunology, 2012
- Role of lapatinib alone or in combination in the treatment of HER2-positive breast cancerBreast Cancer: Targets and Therapy, 2012
- Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classificationVirchows Archiv, 2008
- Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and SurvivorshipMayo Clinic Proceedings, 2008
- Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598Journal of Clinical Oncology, 2004
- Role of HER receptors family in development and differentiationJournal of Cellular Physiology, 2004